- Home
- ONCY vs ATRA Comparison
ONCY vs ATRA Comparison
Compare ONCY & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- ATRA
- Stock Information
- Founded
- ONCY 1998
- ATRA 2012
- Country
- ONCY Canada
- ATRA United States
- Employees
- ONCY N/A
- ATRA N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONCY Health Care
- ATRA Health Care
- Exchange
- ONCY Nasdaq
- ATRA Nasdaq
- Market Cap
- ONCY 49.1M
- ATRA 40.1M
- IPO Year
- ONCY 1999
- ATRA 2014
- Fundamental
- Price
- ONCY $0.92
- ATRA $8.47
- Analyst Decision
- ONCY Strong Buy
- ATRA Buy
- Analyst Count
- ONCY 4
- ATRA 5
- Target Price
- ONCY $4.33
- ATRA $17.75
- AVG Volume (30 Days)
- ONCY 1.4M
- ATRA 41.2K
- Earning Date
- ONCY 07-31-2025
- ATRA 08-11-2025
- Dividend Yield
- ONCY N/A
- ATRA N/A
- EPS Growth
- ONCY N/A
- ATRA N/A
- EPS
- ONCY N/A
- ATRA N/A
- Revenue
- ONCY N/A
- ATRA $199,732,000.00
- Revenue This Year
- ONCY N/A
- ATRA N/A
- Revenue Next Year
- ONCY N/A
- ATRA N/A
- P/E Ratio
- ONCY N/A
- ATRA N/A
- Revenue Growth
- ONCY N/A
- ATRA 475.53
- 52 Week Low
- ONCY $0.33
- ATRA $5.01
- 52 Week High
- ONCY $1.53
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- ONCY 78.48
- ATRA 57.82
- Support Level
- ONCY $0.71
- ATRA $7.54
- Resistance Level
- ONCY $0.81
- ATRA $8.25
- Average True Range (ATR)
- ONCY 0.09
- ATRA 0.48
- MACD
- ONCY 0.02
- ATRA -0.04
- Stochastic Oscillator
- ONCY 89.43
- ATRA 64.09
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).